Literature DB >> 23055019

General transcription factor IIb overexpression and a potential link to proliferation in human hepatocellular carcinoma.

Liren Li1, Aixian Zhang, Xiaolei Cao, Jing Chen, Yunfei Xia, Hui Zhao, Aiguo Shen.   

Abstract

The general transcription factor IIB (TFIIB) plays a central role in preinitiation complex (PIC) assembly, providing a bridge between promoter-bound TFIID and RNA Polymerase II (RNA POLII). TFIIB functionally counteracts the transcriptional activation of hepatitis B virus X protein (HBx), which has been shown to play a role in the development of human hepatocellular carcinoma (HCC). However, the function of TFIIB in HCC remains unclear. In this article, we demonstrate that TFIIB plays an important role in HCC pathogenesis. TFIIB expression was immunohistochemically examined in a series of 100 HCC tissue specimens. The expression level of TFIIB showed significant correlation with the histological grade (P = 0.030), the level of AFP (P = 0.011) and the proliferation marker Ki-67 (P = 0.0002). High TFIIB expression level correlated with poor survival. Western blot analysis also confirmed that the TFIIB protein was overexpressed in HCC tissue compared to benign normal tissue. Additionally, Western blot and qRT-PCR analyses showed a high expression level of TFIIB protein in the HCC cell lines SMMC7721, HepG2, BEL7404, and Huh7 and the immortalized normal line BEL7702 but a lower expression in the normal Chang hepatocyte cell line. Following the release of Huh7 cells from serum starvation, the expression of TFIIB was upregulated. A cell growth assay suggested that TFIIB was involved in the proliferation and growth of HCC cells. In conclusion, our results demonstrate that TFIIB overexpression may play essential roles in the pathogenesis of hepatocellular carcinoma by affecting the proliferation of HCC cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055019     DOI: 10.1007/s12253-012-9569-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP).

Authors:  Wenxiang Wei; Jun Xia Gu; Cui Qing Zhu; Feng Yan Sun; Dorjbal Dorjsuren; Yong Lin; Seishi Murakami
Journal:  Cell Res       Date:  2003-04       Impact factor: 25.617

Review 2.  TFIIB and the regulation of transcription by RNA polymerase II.

Authors:  Wensheng Deng; Stefan G E Roberts
Journal:  Chromosoma       Date:  2007-06-26       Impact factor: 4.316

3.  Hepatitis B virus pX targets TFIIB in transcription coactivation.

Authors:  I Haviv; M Shamay; G Doitsh; Y Shaul
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 4.  Primary liver tumors.

Authors:  W Y Lau
Journal:  Semin Surg Oncol       Date:  2000 Sep-Oct

5.  Structure of an RNA polymerase II-TFIIB complex and the transcription initiation mechanism.

Authors:  Xin Liu; David A Bushnell; Dong Wang; Guillermo Calero; Roger D Kornberg
Journal:  Science       Date:  2009-11-12       Impact factor: 47.728

6.  Basal core promoters control the equilibrium between negative cofactor 2 and preinitiation complexes in human cells.

Authors:  Thomas K Albert; Korbinian Grote; Stefan Boeing; Michael Meisterernst
Journal:  Genome Biol       Date:  2010-03-15       Impact factor: 13.583

7.  Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.

Authors:  Hye Jung Baek; Sung Chul Lim; Krit Kitisin; Wilma Jogunoori; Yi Tang; M Blair Marshall; Bibhuti Mishra; Tae Hyun Kim; Kwan Ho Cho; Sang Soo Kim; Lopa Mishra
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

Review 8.  Hepatocellular carcinoma: current management and recent advances.

Authors:  Wan-Yee Lau; Eric C H Lai
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2008-06

9.  Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.

Authors:  Xiaohua Li; Yanglin Pan; Rui Fan; Haifeng Jin; Shuang Han; Jie Liu; Kaichun Wu; Daiming Fan
Journal:  Carcinogenesis       Date:  2008-02-24       Impact factor: 4.944

10.  TFIIB aptamers inhibit transcription by perturbing PIC formation at distinct stages.

Authors:  Aarti Sevilimedu; Hua Shi; John T Lis
Journal:  Nucleic Acids Res       Date:  2008-04-10       Impact factor: 16.971

View more
  5 in total

1.  Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.

Authors:  Julia E Rager; Sloane K Tilley; Samantha E Tulenko; Lisa Smeester; Paul D Ray; Andrew Yosim; Jenna M Currier; María C Ishida; Maria Del Carmen González-Horta; Blanca Sánchez-Ramírez; Lourdes Ballinas-Casarrubias; Daniela S Gutiérrez-Torres; Zuzana Drobná; Luz M Del Razo; Gonzalo G García-Vargas; William Y Kim; Yi-Hui Zhou; Fred A Wright; Miroslav Stýblo; Rebecca C Fry
Journal:  Chem Res Toxicol       Date:  2015-06-03       Impact factor: 3.739

2.  Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes.

Authors:  Feng Cai; Shasha Chen; Xuebin Yu; Jing Zhang; Weiwei Liang; Yan Zhang; Yike Chen; Sheng Chen; Yuan Hong; Wei Yan; Wei Wang; Jianmin Zhang; Qun Wu
Journal:  Neuro Oncol       Date:  2022-06-01       Impact factor: 13.029

3.  A new paradigm for transcription factor TFIIB functionality.

Authors:  Vladimir Gelev; Janice M Zabolotny; Martin Lange; Makoto Hiromura; Sang Wook Yoo; Joseph S Orlando; Anna Kushnir; Nobuo Horikoshi; Eric Paquet; Dimcho Bachvarov; Priscilla A Schaffer; Anny Usheva
Journal:  Sci Rep       Date:  2014-01-20       Impact factor: 4.379

4.  Proton Beams Inhibit Proliferation of Breast Cancer Cells by Altering DNA Methylation Status.

Authors:  Byungtak Kim; Hansol Bae; Hyunkyung Lee; Seungyeon Lee; Jeong Chan Park; Kye Ryung Kim; Sun Jung Kim
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

5.  Viral targeting of TFIIB impairs de novo polymerase II recruitment and affects antiviral immunity.

Authors:  Darya A Haas; Arno Meiler; Katharina Geiger; Carola Vogt; Ellen Preuss; Georg Kochs; Andreas Pichlmair
Journal:  PLoS Pathog       Date:  2018-04-30       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.